Navigation Links
Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
Date:12/11/2007

PALO ALTO, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) announced today that its Board of Directors has scheduled the company's Annual Meeting of Stockholders for February 14, 2008 with a record date of December 17, 2007. The meeting will be held at the Sheraton Palo Alto, 625 El Camino Real, Palo Alto, California at 4:30 p.m. PT.

The meeting will be webcast by CCBN and can be accessed at Varian Medical Systems' website at http://www.varian.com/investor. To attend the meeting, please RSVP to Anne Rambo, at 650-424-5834, or anne.rambo@varian.com. The meeting will be recorded and a replay will be available on the investor relations page on the company's web site at http://www.varian.com, where it will be archived for a year.

The webcast will also be distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at http://www.fulldisclosure.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (http://www.streetevents.com).

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managi
'/>"/>

SOURCE Varian Medical Systems
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cranberry Could Juice Up Ovarian Cancer Treatment
2. New Ovarian Cancer Drug Trial Under Way
3. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
4. Pelvic Exams Can Help Spot Ovarian Cancer
5. Study fuels debate over whether exercise and body size influence ovarian cancer risk
6. Experimental drug boosts survival in recurrent ovarian cancer
7. New Ovarian Cancer Biomarker Research Act Introduced
8. Common Early-Warning Symptoms of Ovarian Cancer Identified in CDC/Thomson Healthcare Study
9. More Fiber, Less Fat Help Prevent Ovarian Cancer
10. Media availability: low-fat dietary pattern may lower risk of ovarian cancer
11. The Silent Killer, Ovarian Cancer on Your Cancer Today (TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...ire/ -- Pamela Bowen, Chief Information Officer at...or the "Chief Innovation Officer" Appy Award for t...cloud computing. Appy Award recipients are nominat...RM or the Force.com platform in bringing new level...artner, service, support or IT organizations. ,...
(Date:12/4/2009)...kins publishing in the December issue of Neoplasi... "Twist" may be the proverbial red flag that can a...sive, metastatic breast cancer from other breast c...g that it is a relatively rare subgroup of stem ce...ientists have surmised that this subgroup of cells...
(Date:12/4/2009)...ly or 3 weeks later, study shows , , FRI... repair or reconstruction of multiple-ligament kne...tudy has found. , Multiple-ligament knee injuri...n occur in high-impact car crashes or in certain s...ir these injuries hasn,t been definitively establi...
(Date:12/4/2009)...tient groups , , FRIDAY, Dec. 4 (HealthD...wing sarcomas and central nervous system tumors, c... have found. , The study authors analyzed data ... pediatric cancers who were enrolled in the Childh...und that the overall cancer recurrence rate was 4....
(Date:12/4/2009)...owth after heart attack , , FRIDAY, Dec....help repair heart attack damage, a new study shows... stem cells from donor bone marrow promoted the gr...by heart attack. , The patients received the st...t attack. During follow-up, they were compared to ...
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...is a plea on behalf of the HIV positive people of ... their lifetime and after death. Malsawmdawnga who...DS// Society (MPLAS) gave a press talk stating tha... practice of sealing the dead bodies of AIDS patie...
...en an increasing tendency by citizens of Scotland ...ealthy trend were to continue, it would mean a les...e a public ban on smoking the following year. ...compared to the figures in 2003 where merely 40,00...
...rala):A couple who were HIV (Human Immuno-deficien...ill their last breath in Palakkad district of Kera...t before taking this decision and decided not to p...marriage received full support from family, friend...
...a HIV positive mother, who gave birth to HIV negat...ent to provide drugs, information and clean water ...h to HIV negative childs. Auwalu has started an or...event the transmssion of her virus to her child wi...
... the World AIDS day, the Andhra Pradesh State AIDS... Indian Industry (CII) organized an AIDS awareness...ool and // colleges and various corporate and NG...at by 2010 more than 75 million people will be inf...
...ling Asia and causing havoc the bird flu has sprea...have been detected in Ukraine. This has sent p... To ascertain the severity of the flu tests ...lled for by the Ukrainian president in some parts ...
Other Medicine News:Health News:Conditions Of The HIV/AIDS Patients In The Mizo Society 2Health News:Couple infected with HIV marry in Kerala 2
(Date:12/4/2009)...iveries are Transported ,, PHILADELPHIA, Dec....loyed by the Philadelphia chapter of the American ...out the unfair labor conditions that they endure t...ply at risk. More than 100 employees went on stri...ssues were ignored by their employer. ,, Red Cr...
(Date:12/4/2009)...re-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC...rst patient has been enrolled in the company,s Pha...rland for use of Oxycyte(TM) emulsion in traumatic...luorocarbon (PFC) therapeutic oxygen carrier. ,...ving the outcome of patients with severe TBI. We h...
(Date:12/4/2009)...wswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:...ountermeasures against biological and chemical thr... from the Company,s anthrax vaccine program showin...gen (rPA) based anthrax vaccine is structurally st...tures up to and including 55 degrees C. The data ...
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5ACS Technologies 28TM 29 Selects M2SYS for Innovative Biometric Software 9220 1ACS Technologies 28TM 29 Selects M2SYS for Innovative Biometric Software 9220 2US Government Places 6 1 Million USD Orders Related to Precise Match on Card 28TM 29 for Cyber Security Programs 9217 1US Government Places 6 1 Million USD Orders Related to Precise Match on Card 28TM 29 for Cyber Security Programs 9217 2Type of Knee Surgery Makes Difference in Football Career 51400 1Type of Knee Surgery Makes Difference in Football Career 51400 2
...rapeutics,(Alternext: ALEHT) is pleased to announc...und in Alzheimer,s disease, is progressing well. P... EHT 0202 in patients with,Alzheimer,s disease is ...ient enrolment for the Phase IIa,represents an imp...nd,provides a clear timeline for the release of re...
...ket Share Leader Through 2017, According to a New ..., Feb. 25 Decision Resources, one of the world,s ...ical and healthcare issues, finds that a therapy,s...e attribute that most influences surveyed cardiolo...yocardial infarction (NSTEMI). Data and the opinio...
Other Medicine Technology:ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI 2Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI 3
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: